Insider Monitor  
 



Insider Trading: Heartware Ltd

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heartware Ltd in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Heartware Ltd since year 2005. Table 2 shows the detailed insider transactions of Heartware Ltd since 2005. The reporting company's ticker symbol is HTWR. The reporting company's CIK number is 1389072.

The total value of stock buying since 2005 is $6,144,065. The total value of stock sales is $236,082,592. The total value of stock exercises is $5,267,370.
1 year stock price chart,   1 day stock price chart
HTWR 1 year chart
HTWR 1 day chart

Figure 1. Monthly insider transaction values at Heartware Ltd (HTWR) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2012

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2013

  • 02

  • 03

  • 04

  • 05

  • 06

  • $29,975k

    $2,997k

    $299k

    $29k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Heartware Ltd (HTWR) in the past 24 months. See table 2 for insider transaction details.

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2012

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2013

  • 02

  • 03

  • 04

  • 05

  • 06

  • $96.35

    $72.27

    $48.18

    $24.09



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Heartware Ltd (HTWR).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2013-06 0 0 2,656 240,128 0 0
2013-05 0 0 62,234 6,029,695 39,529 661,638
2013-03 0 0 2,500 221,887 5,250 0
2013-02 0 0 1,000 90,590 0 0
2012-12 0 0 367,278 29,975,131 32,549 0
2012-11 0 0 7,062 595,646 13,216 0
2012-09 0 0 38,923 3,590,226 83,500 303,600
2012-08 0 0 13,500 1,206,411 7,500 301,759
2012-07 0 0 43,519 3,925,809 13,062 492,399
2012-06 0 0 13,299 1,129,925 5,000 97,025
2012-05 0 0 29,428 2,331,179 18,008 95,500
2012-04 0 0 33,805 2,636,965 3,786 132,394
2012-03 0 0 8,257 580,454 5,250 0
2012-02 0 0 41,684 3,083,901 4,120 169,952
2012-01 0 0 12,171 856,258 0 0
2011-12 0 0 29,153 2,008,952 20,515 219,474
2011-11 0 0 7,500 474,975 0 0
2011-10 0 0 6,794 475,866 0 0
2011-09 0 0 74,878 4,173,543 108,500 0
2011-08 1,500 90,630 5,000 316,350 0 0
2011-06 0 0 10,000 713,100 0 0
2011-05 2,500 195,450 6,571 492,937 2,338 0
2011-02 0 0 10,890 954,004 17,498 0
2011-01 0 0 18,084 1,638,551 12,544 450,070
2010-12 0 0 2,010,000 156,576,100 0 0
2010-09 0 0 70,988 5,069,541 109,786 35,561
2010-07 0 0 0 0 562 0
2010-06 0 0 11,602 736,537 10,745 275,645
2010-05 0 0 13,488 745,717 6,428 155,814
2010-04 0 0 28,570 1,438,988 21,834 529,593
2010-03 0 0 16,327 653,186 0 0
2010-02 0 0 15,570 607,239 52,494 0
2010-01 0 0 12,458 467,822 5,458 172,425
2009-12 0 0 15,841 503,983 10,529 254,781
2009-11 0 0 24,331 777,656 62,075 754,687
2009-09 0 0 22,513 618,541 0 0
2009-08 3 71 0 0 22,000 129,360
2009-07 0 0 6,410 144,799 0 0
2009-06 0 0 0 0 6,284 35,693
2008-09 220,000 107,566 0 0 0 0
2008-08 4,129,000 2,132,110 0 0 0 0
2008-07 5,350,000 2,568,000 0 0 0 0
2008-06 20,000 9,600 0 0 0 0
2008-05 211,989 77,068 0 0 0 0
2008-04 1,000,000 314,000 0 0 0 0
2008-02 93,000 35,340 0 0 0 0
2007-08 63,000 28,980 0 0 0 0
2007-07 1,036,150 549,159 0 0 0 0
2007-06 72,183 36,091 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Heartware Ltd (HTWR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-06-06 Thomas Robert Bain (Director) Sale 2,656 90.41 240,128
2013-05-30 Thomas Robert Bain (Director) Sale 57 94.05 5,360
2013-05-29 Thomas Robert Bain (Director) Sale 714 93.50 66,762
2013-05-28 Hathaway David R (Chief Medical Officer) Sale 5,934 95.05 564,026
2013-05-28 Hathaway David R (Chief Medical Officer) Option Exercise 4,491 19.22 86,317
2013-05-28 Thomas Robert Bain (Director) Sale 2,786 93.02 259,145
2013-05-22 Hathaway David R (Chief Medical Officer) Sale 2,400 95.15 228,360
2013-05-22 Hathaway David R (Chief Medical Officer) Option Exercise 2,400 19.55 46,920
2013-05-21 Hathaway David R (Chief Medical Officer) Sale 17,140 96.31 1,650,753
2013-05-21 Hathaway David R (Chief Medical Officer) Option Exercise 17,140 19.51 334,401
2013-05-21 Thomas Robert Bain (Director) Sale 200 97.69 19,538
2013-05-20 Knopf Lawrence J (General Counsel) Sale 2,000 97.72 195,440
2013-05-20 Hathaway David R (Chief Medical Officer) Sale 10,000 97.89 978,900
2013-05-20 Hathaway David R (Chief Medical Officer) Option Exercise 10,000 19.40 194,000
2013-05-20 Wade Denis Newell (Director) Sale 4,000 99.00 396,000
2013-05-20 Thomas Robert Bain (Director) Sale 6,429 98.08 630,582
2013-05-20 Larose Jeffrey (Chief Scientific Officer) Sale 9,574 97.94 937,629
2013-05-12 Harrison Seth Loring (Director) Option Exercise 250 .00 0
2013-05-12 Wade Denis Newell (Director) Option Exercise 250 .00 0
2013-05-12 Stockman Robert Bernard (Director) Option Exercise 250 .00 0
2013-05-12 Thomas Robert Bain (Director) Option Exercise 250 .00 0
2013-05-12 Barberich Timothy J (Director) Option Exercise 250 .00 0
2013-05-12 Larkin C Raymond Jr (Director) Option Exercise 250 .00 0
2013-05-04 Harrison Seth Loring (Director) Option Exercise 333 .00 0
2013-05-04 Wade Denis Newell (Director) Option Exercise 333 .00 0
2013-05-04 Stockman Robert Bernard (Director) Option Exercise 333 .00 0
2013-05-04 Thomas Robert Bain (Director) Option Exercise 333 .00 0
2013-05-04 Barberich Timothy J (Director) Option Exercise 333 .00 0
2013-05-04 Larkin C Raymond Jr (Director) Option Exercise 333 .00 0
2013-05-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 97.20 97,200
2013-05-01 Harrison Seth Loring (Director) Option Exercise 250 .00 0
2013-05-01 Wade Denis Newell (Director) Option Exercise 250 .00 0
2013-05-01 Stockman Robert Bernard (Director) Option Exercise 250 .00 0
2013-05-01 Thomas Robert Bain (Director) Option Exercise 250 .00 0
2013-05-01 Feldmann Cynthia L (Director) Option Exercise 500 .00 0
2013-05-01 Barberich Timothy J (Director) Option Exercise 250 .00 0
2013-05-01 Larkin C Raymond Jr (Director) Option Exercise 250 .00 0
2013-03-28 Knopf Lawrence J (General Counsel) Sale 2,500 88.76 221,887
2013-03-28 Knopf Lawrence J (General Counsel) Option Exercise 5,250 .00 0
2013-02-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 90.59 90,590
2012-12-21 Yocher Robert E (SVP, Regulatory & Quality) Sale 426 81.98 34,921
2012-12-21 Yocher Robert E (SVP, Regulatory & Quality) Option Exercise 1,000 .00 0
2012-12-21 Knopf Lawrence J (General Counsel) Sale 639 81.98 52,382
2012-12-21 Knopf Lawrence J (General Counsel) Option Exercise 1,500 .00 0
2012-12-21 Hathaway David R (Chief Medical Officer) Sale 532 81.98 43,610
2012-12-21 Hathaway David R (Chief Medical Officer) Option Exercise 1,250 .00 0
2012-12-21 Schuermann James (SVP, Sales & Marketing) Sale 1,064 81.98 87,226
2012-12-21 Schuermann James (SVP, Sales & Marketing) Option Exercise 2,500 .00 0
2012-12-21 Larose Jeffrey (Chief Scientific Officer) Sale 1,627 81.98 133,381
2012-12-21 Larose Jeffrey (Chief Scientific Officer) Option Exercise 4,375 .00 0
2012-12-21 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,829 81.98 313,882
2012-12-21 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 9,000 .00 0
2012-12-21 Farrell Lauren (VP, Finance) Sale 405 81.97 33,197
2012-12-21 Farrell Lauren (VP, Finance) Option Exercise 1,250 .00 0
2012-12-20 Hathaway David R (Chief Medical Officer) Sale 537 82.09 44,082
2012-12-20 Hathaway David R (Chief Medical Officer) Option Exercise 1,262 .00 0
2012-12-20 Schuermann James (SVP, Sales & Marketing) Sale 532 82.09 43,671
2012-12-20 Schuermann James (SVP, Sales & Marketing) Option Exercise 1,250 .00 0
2012-12-20 Larose Jeffrey (Chief Scientific Officer) Sale 1,042 82.09 85,537
2012-12-20 Larose Jeffrey (Chief Scientific Officer) Option Exercise 2,800 .00 0
2012-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,388 82.09 196,030
2012-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 5,612 .00 0
2012-12-20 Farrell Lauren (VP, Finance) Sale 243 82.08 19,945
2012-12-20 Farrell Lauren (VP, Finance) Option Exercise 750 .00 0
2012-12-14 Harrison Seth Loring (Director) Sale 75,922 81.06 6,153,857
2012-12-13 Hathaway David R (Chief Medical Officer) Sale 5,640 81.10 457,403
2012-12-13 Harrison Seth Loring (Director) Sale 108,571 81.69 8,869,164
2012-12-13 Wade Denis Newell (Director) Sale 2,163 81.00 175,203
2012-12-12 Hathaway David R (Chief Medical Officer) Sale 6,000 81.81 490,860
2012-12-12 Harrison Seth Loring (Director) Sale 11,480 81.82 939,293
2012-12-12 Wade Denis Newell (Director) Sale 337 82.50 27,802
2012-12-11 Hathaway David R (Chief Medical Officer) Sale 6,000 82.17 493,020
2012-12-11 Harrison Seth Loring (Director) Sale 55,358 82.18 4,549,320
2012-12-10 Harrison Seth Loring (Director) Sale 25,500 83.03 2,117,265
2012-12-07 Harrison Seth Loring (Director) Sale 48,130 80.92 3,894,438
2012-12-04 Thomas Robert Bain (Director) Sale 3,600 80.36 289,296
2012-12-03 Schuermann James (SVP, Sales & Marketing) Sale 2,500 81.64 204,100
2012-12-03 Thomas Robert Bain (Director) Sale 1,400 80.60 112,839
2012-12-03 Larose Jeffrey (Chief Scientific Officer) Sale 1,413 80.26 113,407
2012-11-21 Schuermann James (SVP, Sales & Marketing) Sale 800 84.37 67,494
2012-11-21 Larose Jeffrey (Chief Scientific Officer) Sale 909 84.37 76,690
2012-11-21 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,817 84.37 322,032
2012-11-21 Farrell Lauren (VP, Finance) Sale 536 84.74 45,420
2012-11-20 Schuermann James (SVP, Sales & Marketing) Option Exercise 1,786 .00 0
2012-11-20 Larose Jeffrey (Chief Scientific Officer) Option Exercise 2,322 .00 0
2012-11-20 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 8,572 .00 0
2012-11-20 Farrell Lauren (VP, Finance) Option Exercise 536 .00 0
2012-11-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 84.01 84,010
2012-09-18 Hathaway David R (Chief Medical Officer) Sale 916 92.39 84,629
2012-09-18 Schuermann James (SVP, Sales & Marketing) Sale 915 92.39 84,536
2012-09-18 Larose Jeffrey (Chief Scientific Officer) Sale 1,200 92.39 110,868
2012-09-18 Godshall Douglas Evan (President & Chief Exec Officer) Sale 11,162 92.52 1,032,708
2012-09-18 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 7,500 40.48 303,600
2012-09-18 Farrell Lauren (VP, Finance) Sale 69 92.38 6,374
2012-09-17 Hathaway David R (Chief Medical Officer) Sale 3,338 92.09 307,396
2012-09-17 Schuermann James (SVP, Sales & Marketing) Sale 3,339 92.10 307,505
2012-09-17 Larose Jeffrey (Chief Scientific Officer) Sale 4,377 92.09 403,077
2012-09-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 13,352 92.10 1,229,652
2012-09-17 Farrell Lauren (VP, Finance) Sale 255 92.08 23,481
2012-09-16 Hathaway David R (Chief Medical Officer) Option Exercise 10,000 .00 0
2012-09-16 Schuermann James (SVP, Sales & Marketing) Option Exercise 10,000 .00 0
2012-09-16 Larose Jeffrey (Chief Scientific Officer) Option Exercise 15,000 .00 0
2012-09-16 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 40,000 .00 0
2012-09-16 Farrell Lauren (VP, Finance) Option Exercise 1,000 .00 0
2012-08-28 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,146 90.24 283,895
2012-08-28 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 3,146 40.01 125,871
2012-08-24 Godshall Douglas Evan (President & Chief Exec Officer) Sale 1,854 90.09 167,026
2012-08-24 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 1,854 40.38 74,864
2012-08-23 Thomas Robert Bain (Director) Sale 5,000 88.80 444,000
2012-08-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 88.98 222,450
2012-08-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 2,500 40.41 101,024
2012-08-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 89.04 89,040
2012-07-31 Larkin C Raymond Jr (Director) Option Exercise 562 .00 0
2012-07-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 7,500 90.67 680,025
2012-07-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 7,500 39.38 295,350
2012-07-16 Harrison Seth Loring (Director) Sale 19,401 90.21 1,750,164
2012-07-13 Harrison Seth Loring (Director) Sale 9,199 90.00 827,910
2012-07-12 Harrison Seth Loring (Director) Sale 194 90.00 17,460
2012-07-03 Harrison Seth Loring (Director) Sale 525 90.00 47,250
2012-07-02 Schuermann James (VP, Sales & Marketing) Sale 1,000 90.00 90,000
2012-07-02 Harrison Seth Loring (Director) Sale 700 90.00 63,000
2012-07-02 Godshall Douglas Evan (President & Chief Exec Officer) Sale 5,000 90.00 450,000
2012-07-02 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 5,000 39.41 197,049
2012-06-25 Yocher Robert E (SVP, Regulatory & Quality) Sale 1,060 86.41 91,594
2012-06-23 Yocher Robert E (SVP, Regulatory & Quality) Option Exercise 2,500 .00 0
2012-06-18 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 85.81 214,525
2012-06-18 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 2,500 38.81 97,025
2012-06-13 Thomas Robert Bain (Director) Sale 714 85.24 60,861
2012-06-12 Thomas Robert Bain (Director) Sale 5,000 85.61 428,050
2012-06-08 Schuermann James (VP, Sales & Marketing) Sale 1,000 85.00 85,000
2012-06-07 Stockman Robert Bernard (Director) Sale 3,025 82.61 249,895
2012-05-25 Thomas Robert Bain (Director) Sale 428 78.54 33,615
2012-05-23 Thomas Robert Bain (Director) Sale 957 78.34 74,971
2012-05-21 Larose Jeffrey (Chief Scientifc Officer) Sale 1,322 79.83 105,535
2012-05-18 Thomas Robert Bain (Director) Sale 6,429 78.66 505,737
2012-05-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 80.23 200,575
2012-05-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Exercise 2,500 38.20 95,500
2012-05-16 Thomas Robert Bain (Director) Sale 5,000 80.00 400,000
2012-05-15 Thomas Robert Bain (Director) Sale 5,000 80.73 403,650
2012-05-12 Harrison Seth Loring (Director) Option Exercise 250 .00 0
2012-05-12 Bennett Christine Constance (Director) Option Exercise 250 .00 0
2012-05-12 Wade Denis Newell (Director) Option Exercise 250 .00 0
2012-05-12 Stockman Robert Bernard (Director) Option Exercise 250 .00 0
2012-05-12 Thomas Robert Bain (Director) Option Exercise 250 .00 0
2012-05-12 Barberich Timothy J (Director) Option Exercise 250 .00 0
2012-05-12 Larkin C Raymond Jr (Director) Option Exercise 250 .00 0
2012-05-11 Farrell Lauren (VP, Finance) Sale 475 81.73 38,821
2012-05-09 Schuermann James (VP, Sales & Marketing) Sale 313 77.18 24,157
2012-05-09 Larose Jeffrey (Chief Scientifc Officer) Sale 820 77.18 63,287
2012-05-09 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,445 77.18 265,885

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Heartware Ltd (symbol HTWR, CIK number 1389072) see the Securities and Exchange Commission (SEC) website.



©2013, insider-monitor.com. All rights reserved.